Key points GLP-1 is a hormone that increases insulin release and prevents the release of too much glucagon, helping manage blood glucose levels in individuals with type 2 diabetes GLP-1 receptor agonists, such as liraglutide and semaglutide, effectively reduce blood glucose levels Semaglutide is more effective than liraglutide at reducing blood sugar levels Tirzepatide is a newer GLP-1 receptor agonist that also mimics the actions of another hormone called GIP, which can also reduce blood sugar levels A randomised controlled trial showed that tirzepatide led to more significant blood sugar reductions than semaglutide across three doses Tirzepatide may be more effective than semaglutide at higher doses, but this needs further investigation Liraglutide and semaglutide are available in the UK and the US, while tirzepatide is only available in the US but is likely to be approved in the UK soon
Protein Regulation : Through thiol-disulfide exchange reactions, reduced glutathione modulates protein structure and function by reducing oxidized cysteine residues, maintaining proper protein folding and enzymatic activity
BPC-157 promotes the shift from pro-inflammatory M1 to reparative M2 macrophages, facilitating inflammation resolution and reducing scar tissue formation
Among all the bacteria studied in this review, P
According to a study in 2021 by Huijing Xue Et al
.png)
